Alzheimer disease and cerebrovascular pathology: an update
The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Abstract
Recent epidemiological and clinico-pathologic data suggest overlaps between Alzheimer disease (AD) and cerebrovascular lesions that may magnify the effect of mild AD pathology and promote progression of cognitive decline or even may precede neuronal damage and dementia. Vascular pathology in the aging brain and in AD includes: 1. cerebral amyloid angiopathy (CAA) with an incidence of 82-98% often associated with ApoE epsilon 2 and causing a) cerebral mass hemorrhages (around 70%, mainly in the frontal and parietal lobes), b) multiple or recurrent microhemorrhages (15%), and c) ischemic (micro-)infarcts or lacunes (around 20%). The frequency of these lesions increases with the severity of CAA and shows no correlation with that of senile amyloid plaques. CAA, significantly more frequent in patients with cerebral hemorrhages or infarcts than in aged controls, is an important risk factor for cerebrovascular lesions in AD. 2. Microvascular changes with decreased density and structural abnormalities causing regional metabolic and blood-brain barrier dysfunctions with ensuing neuronal damage. In large autopsy series of demented aged subjects, around 80% show Alzheimer type pathology, 20-40% with additional, often minor vascular lesions, 7-10% "pure" vascular dementia, and 3-5% "mixed" dementia (combination of AD and vascular encephalopathy). AD cases with additional minor cerebrovascular lesions have significantly more frequent histories of hypertension or infarcts than "pure" AD patients. Vascular lesions in AD include cortical microinfarcts, subcortical lacunes, white matter lesions / leukoencephalopathy, small hemorrhages and corticosubcortical infarcts, while in mixed type dementia multiple larger or hemispheral infarcts are more frequent. Small infarcts in AD patients have no essential impact on global cognitive decline which mainly depends on the severity of Alzheimer pathology, but in early stage of AD they may influence and promote the development of dementia. Recent studies showed lower density of plaques and tangles in brains with cerebrovascular lesions, and similar severity of dementia was related to fewer AD lesions in brains with than in those without small vascular lesions. Further studies will help to elucidate the risk factors and impact of cerebrovascular lesions on the development and progression of dementia in AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CAA appears in ≈10% to 30% of unselected brain autopsies and 80% to 100% when in the presence of accompanying Alzheimer disease.136”
In the citing paper
“which virtually all individuals with AD and about a third of aged cognitively normal individuals have) [68, 179]”
From Alzheimer's disease: experimental models and reality (2017) · cites this paper as [68]
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 2×
“of currently used neuropathological diagnostic criteria for AD (Mirra et al., 1991; Braak and Braak, 1991; Hyman, 1998).”
BackgroundMethodMirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Observations on the brains of demented old people
Tomlinson, B. E., Blessed, G., & Roth, M. (1970) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(70)90063-8 · Cited by 2,084 · cited 2×
“…to many authors, MD should be diagnosed only if there are sufficient vascular and degenerative lesions to make each diagnosis independently (Tomlinson et al., 1970; Boller et al., 1989; Erkinjuntti, 1988; Jellinger et al., 1990; Mirra et al., 1991), while others suggest the diagnosis of AD…”
Background15-year longitudinal study of blood pressure and dementia
Skoog, I., Nilsson, L., Persson, G., Lernfelt, B., Landahl, S., Palmertz, B., Andreasson, L.-A., Odén, A., & Svanborg, A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90608-x · Cited by 1,726 · cited 1×
“An association between hypertension and AD has been reported in several prospective studies (Skoog et al., 1993, 1996; Hofman et al., 1997; Skoog, 2000; Launer et al., 2000; Meyer et al., 2000; Schmidt et al., 2000; Kivipelto et al., 2001).”
BackgroundKivipelto, M., Helkala, E.-L., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · BMJ · doi:10.1136/bmj.322.7300.1447 · Cited by 1,618 · cited 2×
“An association between hypertension and AD has been reported in several prospective studies (Skoog et al., 1993, 1996; Hofman et al., 1997; Skoog, 2000; Launer et al., 2000; Meyer et al., 2000; Schmidt et al., 2000; Kivipelto et al., 2001).”
Background(2001) · The Lancet · doi:10.1016/s0140-6736(00)03589-3 · Cited by 1,338 · cited 2×
“that came to autopsy, but most patients had mixed disease without clear thresholds of pathological features that predicted dementia (Esiri et al., 2001).”
BackgroundChui, H. C., Victoroff, J. I., Margolin, D., Jagust, W., Shankle, R., & Katzman, R. (1992) · Neurology · doi:10.1212/wnl.42.3.473 · Cited by 1,201 · cited 2×
“, 1991), while in the ADDTC criteria (Chui et al., 1992), a second cerebrovascular disorder in addition to AD must be shown to”
BackgroundCerebral microvascular pathology in aging and Alzheimer's disease
Farkas, E., & Luiten, P. G. M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00068-x · Cited by 1,102 · cited 6×
“…vessels (Claudio, 1996; Farkas et al., 2000) with increase of collagen IV (Kalaria and Pax, 1995) and breakdown of the BBB are considered important factors for disturbances of cerebral metabolism, reduced cerebral blood flow and neural metabolic changes (Shi et al., 2000; Farkas and Luiten, 2001).”
BackgroundInfluentialHofman, A., Ott, A., Breteler, M. M., Bots, M. L., Slooter, A. J., van Harskamp, F., van Duijn, C. N., Van Broeckhoven, C., & Grobbee, D. E. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09328-2 · Cited by 1,062 · cited 4×
“Hypertension and hypercholesterinemia, independent of the ApoE genotype have been shown to be risk factors for AD (Hofman et al., 1997; Skoog et al., 1999).”
BackgroundInfluentialClinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria
Knudsen, K. A., Rosand, J., Karluk, D., & Greenberg, S. M. (2001) · Neurology · doi:10.1212/wnl.56.4.537 · Cited by 1,015
Cited by
Items 201–300 of 681
Miao, J., Vitek, M. P., Xu, F., Previti, M. L., Davis, J., & Van Nostrand, W. E. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1306-05.2005 · Cited by 65
“Fibrillar A deposition in the cerebral vasculature, a condition known as cerebral amyloid angiopathy (CAA), is also commonly found in Alzheimer’s disease (Vinters, 1987; Jellinger, 2002; Rensink et al., 2003).”
BackgroundLeko, M. B., Horvat, L. L., Španić, E., Zubčić, K., Hof, P. R., & Šimić, G. (2023) · Biomedicines · doi:10.3390/biomedicines11041161 · Cited by 71
Alterations in working memory as a function of leukoaraiosis in dementia
Lamar, M., Price, C. C., Libon, D. J., Penney, D. L., Kaplan, E., Grossman, M., & Heilman, K. M. (2006) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2006.07.009 · Cited by 66
Chai, Y. L., Hilal, S., Chong, J. P. C., Ng, Y. X., Liew, O. W., Xu, X., Ikram, M. K., Venketasubramanian, N., Richards, M., Lai, M. K. P., et al. (2016) · Medicine · doi:10.1097/md.0000000000004566 · Cited by 65
“While amyloid plaques and neurofibrillary tangles are recognized as the pathological hallmarks of AD, markers of CeVD, such as white matter hyperintensities (WMHs), lacunar infarcts, and cerebral microbleeds, have been reported in AD brains.([1]) Moreover, both CeVD and AD pathology have common risk factors, such as a…”
BackgroundTian, J., Shi, J., Smallman, R., Iwatsubo, T., & Mann, D. M. A. (2006) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00732.x · Cited by 61
In vivo Detection of Cortical Microinfarcts on Ultrahigh‐Field MRI
Ii, Y., Maeda, M., Kida, H., Matsuo, K., Shindo, A., Taniguchi, A., & Tomimoto, H. (2013) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2012.00722.x · Cited by 63
Richardson, K., C.M. Stephan, B., G. Ince, P., Brayne, C., & E. Matthews, F. (2012) · Current Alzheimer Research · doi:10.2174/156720512801322654 · Cited by 62
“Consistent with previous studies finding more infarcts associated with hypertension [50, 51] we also observed microinfarcts more frequently in those reporting medicated hypertension.”
ResultSerum IL‐8 is a marker of white‐matter hyperintensities in patients with Alzheimer's disease
Zhu, Y., Chai, Y. L., Hilal, S., Ikram, M. K., Venketasubramanian, N., Wong, B., Chen, C. P., & Lai, M. K. P. (2017) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2017.01.001 · Cited by 62
“Several neuroimaging markers of cerebrovascular disease (CeVD), such as white-matter hyperintensities (WMHs), cortical infarct, and lacunes, have been shown to be associated with AD [20], and may exacerbate the severity of dementia [21,22].”
Glymphatic system dysfunction in neurodegenerative diseases
Beschörner, N., & Nedergaard, M. (2024) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001252 · Cited by 66
Skibo, G. G., Lushnikova, I., Voronin, K. Y., Dmitrieva, O., Novikova, T., Klementiev, B., Vaudano, E., Berezin, V., & Bock, E. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04345.x · Cited by 60
“Moreover, it is suggested that ischemic stroke is a common risk factor for Alzheimer’s disease (De Deyn et al., 1999; Egashira et al., 2002; Jellinger, 2002), andmay lead to vascular dementia, the most common form of dementia in the elderly after Alzheimer’s disease (Roman, 2003).”
BackgroundCarey, A. M., & Fossati, S. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12871 · Cited by 68
Le Couteur, D. G., & Lakatta, E. G. (2010) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glq135 · Cited by 59
Vascular risk and genetics of sporadic late-onset Alzheimer’s disease
Panza, F., D’Introno, A., Colacicco, A. M., Basile, A. M., Capurso, C. A., Kehoe, P. G., Capurso, C. A., & Solfrizzi, V. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-003-0071-1 · Cited by 66
“…brain and AD includes cerebral amyloid angiopathy (CAA), causing lobar mass hemorrhages, small or recurrent bleeds and ischemic infarcts, microvascular degeneration, disorder of the blood-brain barrier, white matter lesions, microinfarctions, lacunes, and cerebral hemorrhages (Jellinger, 2002).”
BackgroundNavarro, A., del Valle, E., Astudillo, A., del Rey, C. G., & Tolivia, J. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00315-7 · Cited by 72
“It also appears in normal aging (Ghiso and Frangione, 2001; Jellinger, 2002).”
BackgroundCerebral beta-amyloid angiopathy in aged squirrel monkeys.
Elfenbein, H. A., Rosen, R. F., Stephens, S. L., Switzer, R. C., Smith, Y., Paré, J., Mehta, P. D., Warzok, R., & Walker, L. C. (2007) · PubMed · doi:10.14670/hh-22.155 · Cited by 69
Davis, J., Xu, F., Miao, J., Previti, M. L., Romanov, G. A., Ziegler, K., & Nostrand, W. E. V. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.05.031 · Cited by 63
Libon, D. J., Price, C. C., Garrett, K. D., & Giovannetti, T. (2004) · The Clinical Neuropsychologist · doi:10.1080/13854040490507181 · Cited by 66
“In this sense, hypertension contributes to a compromise in the blood brain barrier (Jellinger, 2002; Olsson et al., 1996).”
BackgroundFunctional magnetic resonance imaging as a dynamic candidate biomarker for Alzheimer's disease
Prvulovic, D., Bokde, A. L. W., Faltraco, F., & Hampel, H. J. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.05.008 · Cited by 70
“An alternative interpretation of the HAROLD phenomenon has been proposed to be aging-induced “dedifferentiation”, an inability to direct cortical activation to focal areas relevant for a given cognitive process and instead inefficiently activating broader or additional cortical areas, including…”
BackgroundInfluentialVitamin K2 Holds Promise for Alzheimer’s Prevention and Treatment
Popescu, A., & German, M. (2021) · Nutrients · doi:10.3390/nu13072206 · Cited by 58
“Autopsies of individuals with dementia revealed that 80% of cases had AD, 7–10% had vascular dementia, and 3–5% had mixed dementia, with vascular lesions being observed in 20–40% of the subjects who had AD [101].”
BackgroundEsiri, M., Chance, S., Joachim, C., Warden, D., Smallwood, A., Sloan, C., Christie, S., Wilcock, G., & Smith, A. D. (2015) · Brain Pathology · doi:10.1111/bpa.12221 · Cited by 55
“These structural changes impair the capacity of affected vessels to supply tissues with the blood they need and lead to cortical infarction and intracerebral hemorrhage in some subjects (15, 28, 50, 54, 81, 82).”
BackgroundRebeck, G. W., Hoe, H.-S., & Moussa, C. E.-H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.083915 · Cited by 54
Vascular cognitive impairment: Modeling a critical neurologic disease in vitro and in vivo
Helman, A. M., & Murphy, M. P. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.12.009 · Cited by 60
“Additionally, CAA contributes to cognitive decline and is themost common vascular pathology associated with AD, present in up to 90% of AD cases [77,78].”
BackgroundZhai, Y., Yamashita, T., Nakano, Y., Sun, Z., Shang, J., Feng, T., Morihara, R., Fukui, Y., Ohta, Y., Hishikawa, N., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160345 · Cited by 56
“Our recent data showed that AD occurs in 69% of the elderly population more than 75 years old with dementia [2], approximately 90% of whom have cerebral amyloid angiopathy (CAA) [1, 3] and white matter lesions (WML) [4].”
Platelets in psychiatric disorders
Ehrlich, D., & Humpel, C. (2012) · World Journal of Psychiatry · doi:10.5498/wjp.v2.i6.91 · Cited by 55
Cognitive Correlates of Cerebral Vasoreactivity on Transcranial Doppler in Older Adults
Shim, Y., Yoon, B., Shim, D. S., Kim, W., An, J., & Yang, D. (2015) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2015.01.031 · Cited by 67
“These alterations affect the blood–brain barrier, vascular contractility, and vascular integrity, thereby resulting in stenosis as well as vascular fragility–promoting cerebral hemorrhages and neuronal injury.(48,49)”
BackgroundNegative association between amyloid plaques and cerebral amyloid angiopathy in Alzheimer's disease
Tian, J., Shi, J., Bailey, K. L., & Mann, D. M. A. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.08.048 · Cited by 61
Matrix metalloproteinase 9–mediated intracerebral hemorrhage induced by cerebral amyloid angiopathy
Zhao, L., Arbel-Ornath, M., Wang, X., Betensky, R. A., Greenberg, S. M., Frosch, M. P., & Bacskai, B. J. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.07.016 · Cited by 53
“Introduction Cerebral amyloid angiopathy (CAA) is the deposition of β-amyloid (Aβ) primarily in cerebral arteries and is present in 10–40% of general autopsies and ≥ 80% of cases of Alzheimer disease (AD) (Glenner and Wong, 1984; Jellinger, 2002; Okazaki et al., 1979; Vinters, 1987).”
BackgroundInfluentialTrebbastoni, A., Marcelli, M., Mallone, F., D’Antonio, F., Imbriano, L., Campanelli, A., de Lena, C., & Gharbiya, M. (2016) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000176 · Cited by 56
“4,25,26 Hence, the changes of CT we found in our patients could resemble, in vivo, the progression of the disease within the eye.”
BackgroundThe Pathophysiology of Heme in the Brain
Gozzelino, R. (2016) · Current Alzheimer Research · doi:10.2174/1567205012666150921103304 · Cited by 49
Genotype and plasma concentration of cystatin C in patients with late-onset Alzheimer disease.
Chuo, L.-J., Sheu, W. H. H., Pai, M.-C., & Kuo, Y.-M. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000100021 · Cited by 38
“As vascular lesions are implicated to participate in the pathogenesis of AD [ ,”
BackgroundTakeda, S. (2008) · Frontiers in Bioscience · doi:10.2741/2839 · Cited by 51
“On the other hand, vascular pathology (microinfarctions, lacunae and cerebral hemorrhages) have been found to be associated with AD (55, 56, 57, 58).”
BackgroundVaccination as a Therapeutic Approach to Alzheimer's Disease
Wisniewski, T., & Boutajangout, A. (2010) · Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20156 · Cited by 51
Plasma β-Amyloid Levels in Cerebral Amyloid Angiopathy-Associated Hemorrhagic Stroke
Hernandez-Guillamon, M., Delgado, P., Penalba, A., Rodriguez-Luna, D., Molina, C. A., Rovira, A., Alvarez-Sabin, J., Boada, M., & Montaner, J. (2012) · Neurodegenerative Diseases · doi:10.1159/000333811 · Cited by 51
Severe Cerebral Amyloid Angiopathy Characterizes an Underestimated Variant of Vascular Dementia
Haglund, M., Sjöbeck, M., & Englund, E. M. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000079192 · Cited by 53
Sporadic cerebral amyloid angiopathy is not a frequent cause of spontaneous brain hemorrhage
Jellinger, K. A., Lauda, F., & Attems, J. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01880.x · Cited by 59
“8%), although signs of hypertension in caseswithCAAassociatedwith ICHhavebeen reported in at least 30–50% [9,10,14].”
BackgroundResultInfluentialSelf-citationCalabria, A. R., & Shusta, E. V. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.07.006 · Cited by 53
Jang, H., Jang, Y. K., Kim, H. J., Werring, D. J., Lee, J. S., Choe, Y. S., Park, S., Lee, J., Kim, K. W., Kim, Y., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04314-7 · Cited by 53
MRI-Visible Perivascular Spaces and Risk of Incident Dementia: The Framingham Heart Study
Romero, J. R., Pinheiro, A., Aparicio, H. J., DeCarli, C. S., Demissie, S., & Seshadri, S. S. (2022) · Neurology · doi:10.1212/wnl.0000000000201293 · Cited by 49
“Any «4 allele 329 (23) 98 (24) 145 (22) 68 (24) 18 (25) 143 (22) 147 (24) 36 (23) 3 (19)”
Cerebral microbleeds in a multiethnic elderly community: Demographic and clinical correlates
Wiegman, A. F., Meier, I. B., Schupf, N., Manly, J. J., Guzman, V. A., Narkhede, A., Stern, Y., Martínez‐Ramírez, S., Viswanathan, A., Luchsinger, J. A., et al. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.07.024 · Cited by 52
“That the vast majority of patients with AD have evidence of CAA at autopsy [14] provides evidence of a mechanistic link between cerebrovascular disease and the pathogenesis of AD.”
BackgroundHelman, A. M., Siever, M., McCarty, K. L., Lott, I. T., Doran, E. W., Abner, E. L., Schmitt, F. A., & Head, E. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180589 · Cited by 57
“We also examined the pathology in the OCTX because it is a common location of CAA in AD [29, 30].”
The Role of Basement Membranes in Cerebral Amyloid Angiopathy
Howe, M. D., McCullough, L. D., & Urayama, A. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.601320 · Cited by 52
“The incidence of CAA increases with aging, affecting 12–100% of patients over the age of 80 (Jellinger, 2002).”
BackgroundInfluentialBullock, R. A., Erkinjuntti, T., Lilienfeld, S., & Gcdp Group (2003) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000074140 · Cited by 49
Yang, J., Ji, Y., Mehta, P. D., Bates, K. A., Sun, Y., & Wısnıewskı, T. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101401 · Cited by 50
“The vast majority of AD patients have some degree of CAA at autopsy, with about 75% having “severe” CAA [3, 4].”
InfluentialIncidence of stroke and seizure in Alzheimer's disease dementia
Cook, M. N., Baker, N. L., Lanes, S., Bullock, R. A., Wentworth, C. E., & Arrighi, H. M. (2015) · Age and Ageing · doi:10.1093/ageing/afv061 · Cited by 48
Aggarwal, N. T., Wilson, R. S., Bienias, J. L., De Jager, P. L., Bennett, D. A., Evans, D. A., & DeCarli, C. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.42 · Cited by 48
Emerging roles for high‐density lipoproteins in neurodegenerative disorders
Bahrami, A., Barreto, G. E., Lombardi, G., Pirro, M., & Sahebkar, A. (2019) · BioFactors · doi:10.1002/biof.1541 · Cited by 47
Katsimpris, A., Karamaounas, A., Sideri, A. M., Katsimpris, J., Georgalas, I., & Petrou, P. (2021) · Eye · doi:10.1038/s41433-021-01648-1 · Cited by 55
McRobb, L. S., McKay, M. J., Gamble, J. R., Grace, M., Moutrie, V., Santos, E. D., Lee, V. S., Zhao, Z., Molloy, M. P., & Stoodley, M. A. (2017) · Aging · doi:10.18632/aging.101225 · Cited by 48
“Radiation is also a risk factor for early dementia, however links to an increased risk of Alzheimer’s disease (AD) lack solid epidemiological evidence, despite the fact that AD is characterized by Aβ plaque formation in the brain parenchyma and that CAA occurs in more than 80% of AD patients [6-8].”
BackgroundLin, K., Smith, A. V., Aspelund, T., Betensky, R. A., Smoller, J. W., Gudnason, V. G., Launer, L. J., & Blacker, D. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.08.002 · Cited by 51
“Lobar CMBs may be caused by CAA [38,39], which is highly prevalent in postmortem analyses of brains of persons with clinical diagnosis of AD dementia [40].”
BackgroundThe neuritic plaque in Alzheimer's disease: perivascular degeneration of neuronal processes
Hansra, G. K., Popov, G., Banaczek, P. O., Vogiatzis, M., Jegathees, T., Goldsbury, C. S., & Cullen, K. M. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.06.009 · Cited by 46
The cerebral circulation and cerebrovascular disease II: Pathogenesis of cerebrovascular disease
Geng, X., Chandra, A., Stone, C., Li, W., & Ding, Y. (2017) · Brain Circulation · doi:10.4103/bc.bc_11_17 · Cited by 47
“hemorrhage (ICH), accounting for 5%–20% of all ICHs in elderly patients, with disease localized to the lobar regions in CAA-associated ICH.[31,34,35] However, studies by Attems et al.”
BackgroundNyakas, C., Felszeghy, K., Szabó, R., Keijser, J. N., Luiten, P. G. M., Szombathelyi, Z., & Tihanyi, K. (2009) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2009.00078.x · Cited by 46
Taylor, J. L., Pritchard, H. A. T., Walsh, K. R., Strangward, P., White, C., Hill‐Eubanks, D. C., Alakrawi, M., Hennig, G. W., Allan, S. M., Nelson, M. T., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2204581119 · Cited by 54
Chen, J., Xiang, P., Duro-Castano, A., Cai, H., Guo, B., Liu, X., Yu, Y., Lui, S., Luo, K., Ke, B., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02426-1 · Cited by 45
“3 Most AD patients experience various vascular dysfunctions, 14 which may be linked to A β 15 and tau 16 – 18 or occur independently of both.”
GDF11 Rejuvenates Cerebrovascular Structure and Function in an Animal Model of Alzheimer’s Disease
Zhang, W., Guo, Y., Li, B., Zhang, Q., Liu, J.-H., Gu, G.-J., Wang, J.-H., Bao, R.-K., Chen, Y.-J., & Xu, J.-R. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170474 · Cited by 45
Peters, R. (2008) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2153 · Cited by 51
“DOI: 10.1002/gps Kim and Lee, 2006; Li et al., 2006; Riemenschneider et al., 2006; Xue and Jia, 2006), male gender at midlife (Kivipelto et al., 2006) and female gender in later life (Jorm and Jolley, 1998; Fratiglioni et al., 2000; Lobo et al., 2000).”
BackgroundInfluentialPahlavian, S. H., Wang, X., Ma, S. J., Zheng, H., Casey, M., D’Orazio, L. M., Shao, X., Ringman, J. M., Chui, H. C., Wang, D. J. J., et al. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20927101 · Cited by 48
Petralla, S., Panayotova, M., Franchina, E., Fricker, G., & Puris, E. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16070948 · Cited by 49
“Thus, accumulation of A β on the walls of cerebral blood vessels, known as cerebral amyloid angiopathy (CAA), commonly occurs in AD patients [49–51].”
BackgroundGuarding the Blood–Brain Barrier: A Role for Estrogen in the Etiology of Neurodegenerative Disease
SOHRABJI, F. (2006) · Gene Expression · doi:10.3727/000000006781510723 · Cited by 44
“In humans, studying gender differences in blood to brain transfer of biomolecules is challenging, aldisruption (47,48,116).”
BackgroundJiang, Z., Richardson, J. S., & Yu, P. H. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00886.x · Cited by 48
Current pathophysiological concepts in cerebral small vessel disease
Rincón, F., & Wright, C. B. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00024 · Cited by 58
“Among the important causes of stroke, hypertensionrelated small vessel disease (SVD) and cerebral amyloid angiopathy (CAA) are the most common forms, and have generated significant academic interest because of their sinister impact on brain function.”
BackgroundInfluentialShapira, R., Gdalyahu, A., Gottfried, I., Sasson, E., Hadanny, A., Efrati, S., Blinder, P., & Ashery, U. (2021) · Aging · doi:10.18632/aging.203485 · Cited by 49
Phosphatidylinositol-3-kinase activation blocks amyloid beta-induced neurotoxicity
Lee, K., Koh, S., Noh, M., Kim, S. H., & Lee, Y. J. (2007) · Toxicology · doi:10.1016/j.tox.2007.09.020 · Cited by 45
Goñi, F., Herline, K., Peyser, D., Wong, K., Ji, Y., Sun, Y., Mehta, P., & Wisniewski, T. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-150 · Cited by 43
“In summary, we found that a novel active immunization approach, using pBri in an oligomer conformation, is able to ameliorate all the cardinal lesions of AD pathology, amyloid plaques, CAA and NFTs, without apparent toxicity in different animal models that illustrate each of these pathologies.”
BackgroundInfluentialCerebral amyloidal angiopathy—A disease with implications for neurology and psychiatry
Gahr, M., Nowak, D. A., Connemann, B. J., & Schönfeldt‐Lecuona, C. (2013) · Brain Research · doi:10.1016/j.brainres.2013.04.052 · Cited by 50
Gonzalez‐Velasquez, F. J., & Moss, M. A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04988.x · Cited by 47
Liu, R., Li, J.-Z., Song, J.-K., Sun, J., Li, Y., Zhou, S., Zhang, T., & Du, G. (2014) · BioMed Research International · doi:10.1155/2014/470393 · Cited by 46
“Cerebrovascular deficiencies involved in CAA are paralleled by A𝛽-mediated responses in cultured endothelial cells [9–11], indicating that A𝛽 can elicit cerebrovascular deficits that contribute to disease progression.”
BackgroundInfluentialOlfactory dysfunction persists after smoking cessation and signals increased cardiovascular risk
Siegel, J. K., Wroblewski, K., McClintock, M. K., & Pinto, J. M. (2019) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22357 · Cited by 43
Pons, V., Lévesque, P., Plante, M.-M., & Rivest, S. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-020-00747-7 · Cited by 44
Neurovascular coupling in Alzheimer patients: Effect of acetylcholine-esterase inhibitors
Rosengarten, B., Paulsen, S., Burr, O., & Kaps, M. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.02.017 · Cited by 47
Blood pressure, smoking and alcohol use, association with vascular dementia
Peters, R. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.05.018 · Cited by 44
Boada, M., Ramos‐Fernández, E., Guivernau, B., Muñoz, F. J., Costa, M., Ortiz, A. M., Jorquera, J. I., Núñez, L., Torres, M., & Páez, A. (2014) · Neurología · doi:10.1016/j.nrl.2014.02.003 · Cited by 43
Recent progress in the development of metal complexes as β-amyloid imaging probes in the brain
Chen, K.-H., & Cui, M. (2017) · MedChemComm · doi:10.1039/c7md00064b · Cited by 44
Can the retina be used to diagnose and plot the progression of Alzheimer's disease?
Mahajan, D., & Votruba, M. (2017) · Acta Ophthalmologica · doi:10.1111/aos.13472 · Cited by 49
“In amyloid angiopathy, beta-amyloid deposits in the walls of arteries and arterioles result in a narrowed lumina and eventually occlusion (Ellis et al. 1996; Vinters et al. 1996; Jellinger 2002; Tian et al. 2006).”
BackgroundTherapeutic approaches for prion and Alzheimer's diseases
Wısnıewskı, T., & Sigurdsson, E. M. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05919.x · Cited by 45
Prevalence of vascular lesions in Dementia with Lewy Bodies. A postmortem study
Jellinger, K. A. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-003-0824-x · Cited by 45
“Such acute CVLs had been observed in 1.8% of PD cases and in 2.6% of age-matched controls (Jellinger, 2002c).”
BackgroundResultInfluentialSelf-citationCerebral amyloid angiopathy in aged Chinese: a clinico-neuropathological study
Xu, D., Yang, C., & Wang, L. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0706-1 · Cited by 48
“According to different reports, the prevalence of CAA in aged brains varied from 10% to almost 100% [ 5 ].”
BackgroundResultRetinal and Cerebral Microvasculopathy: Relationships and Their Genetic Contributions
van de Kreeke, J. A., Nguyen, H., Konijnenberg, E., Tomassen, J., den Braber, A., ten Kate, M., Sudre, C. H., Barkhof, F., Boomsma, D. I., Tan, H. S., et al. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-25341 · Cited by 40
“Vascular dementia is an obvious example, but also in diseases such as Alzheimer’s disease, vascular changes play an important role.(7,8) These pathologic vascular changes of the brain are summarized under the term cerebral small vessel disease, such as white matter hyperintensities on MRI.”
BackgroundContribution of blood platelets to vascular pathology in Alzheimer's disease
Zhang, W., Huang, & Fang, J. (2013) · Journal of Blood Medicine · doi:10.2147/jbm.s45071 · Cited by 42
“Studies(42) have demonstrated that in human embryonic kidney (HEK)/ APPsw, CD40wt, and the CD40-mutant cells, CD40L can increase levels of Aβ (1-40), Aβ (1-42), sAPPβ, sAPPα, and CTFβ.”
Independent Effects of Intra- and Extracellular Aβ on Learning-Related Gene Expression
Wegenast‐Braun, B. M., Maisch, A. F., Eicke, D., Radde, R., Herzig, M. C., Staufenbiel, M., Jucker, M., & Calhoun, M. E. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090044 · Cited by 43
Désesquelles, A., Demuru, E., Salvatore, M. A., Pappagallo, M., Frova, L., Meslé, F., & Egidi, V. (2014) · Journal of Aging and Health · doi:10.1177/0898264313514443 · Cited by 47
“Heart and vascular diseases are potential risk factors for AD and dementia, namely, through the ischemic damage they cause; some studies also implicate cardiovascular risk factors as independent factors for AD and dementia (Duthie, Chew, & Soiza, 2011; Jellinger, 2002; Justin, Turek, & Hakim, 2013).”
BackgroundPrevalence and Effects of Lobar Microhemorrhages in Early-Stage Dementia
Atri, A., Locascio, J. J., Lin, J. M., Yap, L., Dickerson, B. C., Grodstein, F., Irizarry, M. C., Growdon, J. H., & Greenberg, S. M. (2005) · Neurodegenerative Diseases · doi:10.1159/000092317 · Cited by 40
“in autopsies of 20‐40% of nondemented older adults and 80‐100% of those with AD [4, 5 ] . Autopsy studies have estimated the prevalence of CAA-related microhemor-”
BackgroundInfluentialTian, J. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.012096 · Cited by 39
“The extent of CAA has been linked in some studies to possession of the ApoE e4 allele, 4 5 7 25–27 especially in patients with the e4/e4 genotype, 6 7 but other workers 28 29 have not found such an association.”
Clifford, P. M., Siu, G., Kosciuk, M. C., Levin, E. C., Venkataraman, V., D’Andrea, M. R., & Nagele, R. G. (2008) · Brain Research · doi:10.1016/j.brainres.2008.07.092 · Cited by 42
“…and progression of a number of neurodegenerative diseases including Alzheimer's disease (AD) (Bailey et al., 2004; Buee et al., 1997; de la Torre . and Hachinski, 1997; de la Torre, 2004; Esiri et al., 1997; Farkas and Luiten, 2001; Jellinger, 2002; Pluta et al., 1996; Zlokovic, 2005, 2008).”
InfluentialSuidan, G. L., Singh, P. K., Patel-Hett, S. R., Chen, Z., Volfson, D., Yamamoto‐Imoto, H., Norris, E. H., Bell, R. D., & Strickland, S. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018017798 · Cited by 40
Blood-brain barrier and innate immunity in the pathogenesis of Alzheimer's disease
Šimić, G., Španić, E., Horvat, L. L., & Hof, P. R. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.06.003 · Cited by 41
Targeting Systemic Innate Immune Cells as a Therapeutic Avenue for Alzheimer Disease
Pons, V., & Rivest, S. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000400 · Cited by 43
“AD is also characterized by an accumulation of amyloid in cerebral vasculature, named cerebral amyloid angiopathy (CAA) (Brenowitz et al., 2015).”
BackgroundInfluentialImmunotherapeutic approaches for Alzheimer’s disease in transgenic mouse models
Wısnıewskı, T., & Boutajangout, A. (2009) · Brain Structure and Function · doi:10.1007/s00429-009-0236-2 · Cited by 40
“Furthermore CAA is present in about 33% of cognitively normal elderly, control populations (Zhang-Nunes et al. 2006).”
BackgroundInfluentialCerebral amyloid angiopathy impact on endothelium
Grinberg, L. T., Korczyn, A. D., & Heinsen, H. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.08.005 · Cited by 39
“CAA is characterized by deposition of amyloid formed mainly from beta-amyloid peptides (Aβ) in the walls of leptomeningeal and parenchymal vessels (Jellinger, 2002).”
Ashraf, G., McGuinness, M. B., Khan, M. A., Obtinalla, C., Hadoux, X., & van Wijngaarden, P. (2023) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12421 · Cited by 61
Roy, S. S., & Rauk, A. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2004.08.031 · Cited by 43
“Alzheimer’s disease is almost always associated with extensive cerebral capillary angiopathy [in the affected areas] and usually some other cerebral macrovascular damage [38–41].”
BackgroundInfluentialA Novel Transgenic Rat Model of Robust Cerebral Microvascular Amyloid with Prominent Vasculopathy
Davis, J., Xu, F., Hatfield, J. T., Lee, H., Hoos, M. D., Popescu, D. L., Crooks, E. J., Kim, R., Smith, S. O., Robinson, J. K., et al. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.07.030 · Cited by 44
Genetics of Vascular Cognitive Impairment
Markus, H. S., & Schmidt, R. (2019) · Stroke · doi:10.1161/strokeaha.118.020379 · Cited by 40
Strategies for molecular imaging dementia and neurodegenerative diseases
Schaller, B. J. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s2154 · Cited by 38
“Neuropathology and structural MRI have pointed to the medial temporal lobe as the brain region earliest affected in AD (Jellinger 2002; Hund-Georgiadis et al 2003).”
Autoregulation of Cerebral Blood Flow to Changes in Arterial Pressure in Mild Alzheimer's Disease
Zazulia, A. R., Videen, T. O., Morris, J. C., & Powers, W. J. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.135 · Cited by 40
“Considerable evidence links cerebrovascular disease with the development and expression of Alzheimer’s disease (AD) (Farkas and Luiten, 2001; Jellinger, 2002).”
BackgroundHereditary and Sporadic Forms of Aβ-Cerebrovascular Amyloidosis and Relevant Transgenic Mouse Models
Kumar-Singh, S. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10041872 · Cited by 38
“However, CAA caused by Aβ is the most common form of sporadic CAA and also occurs in AD patients [1,2,3].”
BackgroundLamar, M., Price, C. C., Giovannetti, T., Swenson, R., & Libon, D. J. (2010) · Behavioural Neurology · doi:10.1155/2010/505979 · Cited by 40
(2015) · Europe PMC (PubMed Central) · Cited by 37
Modeling Alzheimer’s disease with human iPS cells: advancements, lessons, and applications
Essayan-Perez, S., Zhou, B., Nabet, A. M., Wernig, M., & Huang, Y. A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104503 · Cited by 45
“Over 90% of AD patients have mild cerebral amyloid angiopathy, in which Aβ forms deposits in the capillaries and deteriorates the blood-brain barrier (BBB), a key mediator of cerebral homeostasis (Abbott et al., 2010; Jellinger, 2002).”
BackgroundSmall, G. W., Erkinjuntti, T., Kurz, A., & Lilienfeld, S. (2003) · CNS Drugs · doi:10.2165/00023210-200317120-00004 · Cited by 37
Metadata
- Authors
- Jellinger, K. A.
- Affiliations
- Ludwig Boltzmann für Klinische Neurobiologie (AT)
- Corresponding author
- Jellinger, K. A.
- ORCID
- Jellinger, K. A.
- Venue
- Journal of Neural Transmission
- Published
- 2002-05-01
- Volume
- 109
- Issue
- 5-6
- Pages
- 813-836
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W2084675121
- Cited by
- 680
- References
- 114
- Citations by year
- 2026: 7 · 2025: 25 · 2024: 32 · 2023: 19 · 2022: 38 · 2021: 32 · 2020: 22 · 2019: 26 · 2018: 23 · 2017: 22 · 2016: 30 · 2015: 44 · 2014: 38 · 2013: 27 · 2012: 39
- FWCI
- 14.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Neural Transmission (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, cerebrovascular pathology, cerebral amyloid angiopathy, cerebral hemorrhage, microinfarcts, lacunes, white matter lesions, mixed dementia, vascular dementia, cognitive decline, dementia progression, blood-brain barrier dysfunction
- MeSH terms
- Alzheimer Disease, Blood Vessels, Cerebrovascular Circulation, Cerebrovascular Disorders, Diagnosis, Differential, Humans, Microcirculation, Risk Factors, Dementia, Vascular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.